NAVCO Pharmaceuticals Inc. (TSXV:NAV)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Aug 18, 2026, 2:19 PM EST
NAVCO Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
285.35K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | - | - | - |
| Sep 30, 2024 | - | - | - |
| Sep 30, 2023 | - | - | - |
| Sep 30, 2022 | 58.73K | 43.21K | 278.32% |
| Sep 30, 2021 | 15.53K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vibe Growth | 25.35M |
| Adastra Holdings | 16.86M |
| Vencanna Ventures | 2.75M |
| Aequus Pharmaceuticals | 918.47K |
| Optimind Pharma | 121.29K |
| Genix Pharmaceuticals | 68.00 |
| Planet Based Foods Global | -356.97K |
| Captor Capital | -5.17M |